OBJECTIVE. Inflammatory pseudotumor of the liver is a localized mass c
onsisting of a fibrous stroma and chronic inflammatory infiltrate with
out anaplasia. Diagnosis of this rare disease is important to avoid su
rgery. The purpose of this study was to determine if CT is useful in t
he diagnosis of this lesion. SUBJECTS AND METHODS. CT scans of nine pa
tients with a proved diagnosis of inflammatory pseudotumor of the live
r were reviewed. Diagnosis was made by the surgical resection in three
patients and by percutaneous biopsy in six patients. Six patients had
symptoms and laboratory data suggesting active inflammation caused by
the pseudotumor. The remaining three patients were asymptomatic. CT s
cans were performed with IV administration of the contrast material; s
cans were obtained in the portal venous and delayed phases in six pati
ents and in the delayed phase in three patients. CT scans were analyze
d for the number and size of the hepatic masses, and the degree and pa
ttern of contrast enhancement on portal venous phase and delayed-phase
images. RESULTS. Eight patients had a solitary hepatic mass, and one
patient had two masses on the CT scan. The average size of the masses
in the symptomatic patients (8.3 cm) was larger than that in the asymp
tomatic group (3.6 cm). CT scans in the portal venous phase showed a v
ariable degree of contrast enhancement (seven masses). At least a part
of seven masses, six of which were in symptomatic patients, showed gr
eater contrast enhancement on delayed-phase CT scans than on the norma
l liver parenchyma. No constant pattern of enhancement was observed on
delayed-phase CT scans in asymptomatic patients. CONCLUSION. inflamma
tory pseudotumor of the liver should be included in a differential dia
gnosis in patients with a hepatic mass on a CT scan, especially when p
atients are symptomatic and the mass is fairly large and solitary show
ing contrast enhancement greater than that of liver parenchyma on dela
yed phase CT scans. Percutaneous biopsy should be performed to obtain
a histologic confirmation.